🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

UnitedHealth Group Incorporated UNH SPX

Healthcare · Healthcare Plans · United States
https://www.unitedhealthgroup.com

UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; Medicaid plans, including Temporary Assistance to Needy Families; Children's Health Insurance Programs; Dual SNPs; Long-Term Services and Supports; Aged, Blind and Disabled; and other federal, state, and community health care programs. and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.

READ MORE ›
$380.31
+29.52% 1Y

Market & Price

Market Cap
$345.38B
Current Price
$380.31
High / Low (52W)
$401.16 / $232.89
Beta
0.65

Valuation

Stock P/E
28.66
Industry PE
23.65
Forward P/E
18.22
PEG Ratio
1.32
Book Value
$107.80
Price to Book
3.53
P/S
0.77
EV/EBITDA
18.61
Dividend Yield
2.32%

Profitability & Returns

ROCE
9.60%
ROE
12.18%
ROA
3.78%
Profit Margin
2.68%
Op Margin
8.05%
EPS (Latest Qtr)
$6.90
EPS (TTM)
$13.27

Balance Sheet & Liquidity

Debt/Equity
0.74
Quick Ratio
0.72
Current Ratio
0.80
Debt
$77.92B
Total Assets
$309.58B
Current Assets
$90.58B
Working Capital
$-24.32B

Ownership

Promoter Holding
0.24%
Chg in Prom Hold
-
FII / Inst Holding
85.83%
Chg in FII Hold
0.01%

Financial Snapshot

Enterprise Value
$399.50B
Total Revenue (TTM)
$449.71B
EBITDA
$21.46B
Free Cash Flow
$17.69B
Operating Cash Flow
$23.15B
Shares Outstanding
908.14M
Gross Margin
18.80%
Payout Ratio
66.57%

Growth (CAGR)

Revenue 5Y
11.35%
Profit 5Y
-15.69%
Revenue (YoY)
2.00%
Earnings (YoY)
0.70%

PROS

  • Compounding revenue at 11.4% over 5 years.
  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Earnings shrank at -15.7% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 UNH UnitedHealth Group Incorporated SPX 380.31 28.66 $345.38B 2.32% 9.60% 12.18% 11.35% -15.69%
2 LLY Eli Lilly and Company SPX 1,105.00 39.21 $985.37B 0.63% 38.44% 107.46% 31.69% 48.96%
3 JNJ Johnson & Johnson SPX 225.33 26.11 $542.42B 2.38% 23.13% 26.42% 5.60% 14.32%
4 MRK Merck & Co., Inc. SPX 118.72 33.44 $293.22B 2.86% 20.66% 18.94% 3.12% 7.93%
5 TMO Thermo Fisher Scientific Inc. SPX 492.51 27.11 $183.03B 0.38% 9.17% 13.52% -0.27% -1.19%
6 AMGN Amgen Inc. NDXSPX 336.79 23.42 $181.77B 2.99% 18.02% 101.32% 11.77% 5.58%
7 GILD Gilead Sciences, Inc. NDXSPX 134.43 18.29 $166.90B 2.44% 22.92% 43.36% 2.57% 22.83%
8 ISRG Intuitive Surgical, Inc. NDXSPXAI 424.64 51.53 $150.39B - 15.96% 17.23% 17.39% 29.26%
9 PFE Pfizer Inc. SPX 26.18 19.98 $149.21B 6.57% 5.95% 8.31% -14.80% -37.20%
Ad space

Quarterly Results

Figures in USD.

Metric Sep 2013Dec 2013Mar 2014Jun 2014Sep 2014Mar 2015Jun 2015Sep 2015Mar 2016Jun 2016Sep 2016Mar 2017Jun 2017Sep 2017Mar 2018Jun 2018Sep 2018Mar 2019Jun 2019Sep 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 30.62B31.12B31.71B32.57B32.76B35.76B36.26B41.49B44.53B46.48B46.29B48.72B50.05B50.32B55.19B56.09B56.56B60.31B60.59B60.35B64.42B62.14B65.11B70.20B71.32B72.34B80.15B80.33B80.89B91.93B92.90B92.36B99.80B98.86B-109.58B111.62B113.16B113.22B111.72B
Cost of Revenue -----------------------------------85.80B91.60B92.52B94.72B86.31B
Gross Profit -----------------------------------23.77B20.01B20.64B18.49B25.41B
Operating Expenses -----------------------------------14.65B14.86B16.32B18.11B16.42B
Operating Income 2.63B2.45B2.05B2.55B2.90B2.64B2.90B3.02B2.96B3.20B3.58B3.41B3.73B4.09B4.05B4.20B4.59B4.83B4.74B5.01B5.00B9.24B4.65B6.74B5.98B5.71B6.95B7.13B7.46B8.09B8.06B8.53B7.93B7.88B-9.12B5.15B4.32B380.00M8.99B
EBITDA -----------------------------------10.16B6.19B5.33B1.37B9.95B
Interest Expense -----------------------------------998.00M1.03B1.00B974.00M955.00M
Pretax Income -----------------------------------8.11B4.08B3.23B-720.00M7.96B
Tax Provision -----------------------------------1.63B510.00M686.00M-938.00M1.48B
Net Income 1.57B1.43B1.10B1.41B1.60B1.41B1.58B1.60B1.61B1.75B1.97B2.17B2.28B2.48B2.84B2.92B3.19B3.47B3.29B3.54B3.38B6.64B3.17B4.86B4.27B4.09B5.03B5.07B5.26B5.61B5.47B5.84B-1.41B4.22B-6.29B3.41B2.35B10.00M6.28B
Diluted EPS 1.531.411.101.421.631.461.641.651.671.812.032.232.322.512.872.983.243.563.423.673.526.913.305.084.464.285.275.345.555.955.826.24-1.534.54-6.853.742.590.016.90

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 75.43B81.19B87.14B94.16B101.86B110.62B122.49B130.47B157.11B184.84B201.16B226.25B242.16B257.14B-324.16B371.62B400.28B447.57B
Cost of Revenue ---------------244.54B280.66B310.88B364.65B
Gross Profit ---------------79.62B90.96B89.40B82.92B
Operating Expenses ---------------51.18B58.60B57.11B63.95B
Operating Income 7.85B5.26B6.36B7.86B8.46B9.25B9.62B10.27B11.02B12.93B15.21B17.34B19.68B22.41B-28.43B32.36B32.29B18.96B
EBITDA ---------------31.84B36.33B28.08B23.06B
Interest Expense ---------------2.09B3.25B3.91B4.00B
Pretax Income ---------------26.34B29.11B20.07B14.70B
Tax Provision ---------------5.70B5.97B4.83B1.89B
Net Income 4.65B2.98B3.82B4.63B5.14B5.53B5.62B5.62B5.81B7.02B10.56B11.99B13.84B15.40B-20.12B22.38B14.40B12.06B
Diluted EPS 3.422.403.244.104.735.285.505.706.017.2510.7212.1914.3316.03-21.1823.8615.5113.23

Compounded Sales Growth

5 Years:11.35%
1 Year:2.00%

Compounded Profit Growth

5 Years:-15.69%
1 Year:0.70%

Stock Price Performance

1 Year:+29.52%
6 Months:+18.26%
3 Months:+30.69%
1 Month:+2.58%

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2006Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --55.81B59.05B63.06B67.89B80.89B81.88B86.30B111.25B122.81B139.06B152.22B173.89B197.29B-245.71B273.72B298.28B309.58B
Current Assets ----------------69.07B78.44B85.78B90.58B
Cash & Equivalents 10.32B8.87B7.43B9.80B9.12B9.43B8.41B7.28B7.50B10.92B10.43B11.98B10.87B10.98B16.92B-23.36B25.43B25.31B24.36B
Inventory --------------------
Receivables ----------------17.68B21.28B22.36B23.02B
Total Liabilities --35.03B35.44B37.24B39.60B47.59B48.56B52.54B75.79B82.62B87.04B95.99B111.73B126.75B-159.36B174.80B195.69B207.88B
Current Liabilities --19.76B22.16B23.70B23.92B27.12B27.88B30.62B42.90B49.25B50.46B53.21B61.78B72.42B-89.24B99.05B103.77B114.90B
Long Term Debt --11.34B9.01B8.66B10.66B14.04B14.89B16.01B25.33B25.78B28.84B34.58B36.81B38.65B-54.51B58.26B72.36B72.32B
Total Debt ----------------57.62B62.54B76.90B78.39B
Total Equity 20.81B20.06B20.78B23.61B25.82B28.29B31.18B32.15B32.45B-------77.77B88.76B92.66B94.11B
Shares Outstanding ----------------934.00M924.00M915.00M905.84M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 5.88B4.24B5.62B6.27B6.97B7.16B6.99B8.05B9.74B9.79B13.60B15.71B18.46B22.17B-26.21B29.07B24.20B19.70B
Investing Cash Flow -4.15B-5.07B-976.00M-5.34B-4.17B-8.65B-3.09B-2.53B-18.39B-9.36B-8.60B-12.38B-12.70B-12.53B--28.48B-15.57B-20.53B-8.69B
Financing Cash Flow -3.19B-605.00M-2.27B-1.61B-2.49B471.00M-4.95B-5.29B12.24B-1.01B-3.44B-4.37B-5.62B-3.59B-4.23B-11.53B-3.51B-11.64B
Capital Expenditure -871.00M-791.00M-739.00M-878.00M-1.07B-1.07B-1.31B-1.52B-1.56B-1.71B-2.02B-2.06B-2.07B-2.05B--2.80B-3.39B-3.50B-3.62B
Free Cash Flow 5.01B3.45B4.89B5.39B5.90B6.08B5.68B6.53B8.18B8.09B11.57B13.65B16.39B20.12B-23.40B25.68B20.70B16.07B
Net Change in Cash ---------------1.96B1.97B165.00M-632.00M
Share Buybacks 6.60B2.68B1.80B2.52B2.99B3.08B3.17B4.01B1.20B1.28B1.50B4.50B5.50B4.25B5.00B7.00B8.00B9.00B5.54B
Dividends Paid 40.00M37.00M36.00M449.00M651.00M820.00M1.06B------------

Ratios (Annual)

Figures in %.

Metric Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % ---------------24.6%24.5%22.3%18.5%
Operating Margin % 10.4%6.5%7.3%8.4%8.3%8.4%7.9%7.9%7.0%7.0%7.6%7.7%8.1%8.7%-8.8%8.7%8.1%4.2%
Net Margin % 6.2%3.7%4.4%4.9%5.0%5.0%4.6%4.3%3.7%3.8%5.2%5.3%5.7%6.0%-6.2%6.0%3.6%2.7%
ROE % 23.2%14.3%16.2%17.9%18.2%17.7%17.5%17.3%-------25.9%25.2%15.5%12.8%
ROCE % -14.6%17.2%20.0%19.3%17.2%17.8%18.5%16.1%17.6%17.2%17.5%17.6%17.9%-18.2%18.5%16.6%9.7%

Shareholding Pattern

Insiders
0.24%
Institutions
85.83%
Public Float
86.03%

Top Institutional Holders

#Holder% HeldSharesValue
1 Blackrock Inc. 8.09% 73.47M $27.94B
2 Vanguard Capital Management LLC 6.48% 58.87M $22.39B
3 State Street Corporation 4.99% 45.33M $17.24B
4 Capital World Investors 3.06% 27.78M $10.57B
5 Vanguard Portfolio Management LLC 2.65% 24.04M $9.14B
6 Geode Capital Management, LLC 2.51% 22.77M $8.66B
7 Price (T.Rowe) Associates Inc 2.30% 20.87M $7.94B
8 Charles Schwab Investment Management, Inc. 2.29% 20.82M $7.92B
9 JPMORGAN CHASE & CO 2.10% 19.10M $7.26B
10 Capital Research Global Investors 1.88% 17.11M $6.51B

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for UNH

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks